Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
cancer immunotherapy
2
×
clinical trials
2
×
deals
2
×
immunotherapy
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
acute myeloid leukemia
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alx oncology
alzheimer's disease
antibiotics
autoimmune diseases
axial spondyloarthritis
bausch health
berkeley lights
biogen
biotech ipos
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer drugs
car-t immunotherapy
cd47
What
companies
new
2
×
approval
arrival
bio
biogen’s
biopharmaceutical
biotech
convo
days
drug
earlier
failures
hasn’t
industry
ipo
ipos
life
littered
market
momentum
nash
news
price
raised
remains
research
road
roundup
science
slowed
strategy
street
summer’s
talk
wall
week
welcomed
Language
unset
Current search:
biotech
×
deals
×
" clinical trials "
×
" cancer immunotherapy "
×
new
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More